BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 25704723)

  • 1. Microparticle analysis in disorders of hemostasis and thrombosis.
    Mooberry MJ; Key NS
    Cytometry A; 2016 Feb; 89(2):111-22. PubMed ID: 25704723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tissue factor-exposing microparticles.
    Lechner D; Weltermann A
    Thromb Res; 2008; 122 Suppl 1():S47-54. PubMed ID: 18691500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microparticles in hemostasis and thrombosis.
    Owens AP; Mackman N
    Circ Res; 2011 May; 108(10):1284-97. PubMed ID: 21566224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry.
    Erdbrügger U; Rudy CK; Etter ME; Dryden KA; Yeager M; Klibanov AL; Lannigan J
    Cytometry A; 2014 Sep; 85(9):756-70. PubMed ID: 24903900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-resolved calibration-free flow cytometric characterization of platelets and cell-derived microparticles in platelet-rich plasma.
    Konokhova AI; Chernova DN; Moskalensky AE; Strokotov DI; Yurkin MA; Chernyshev AV; Maltsev VP
    Cytometry A; 2016 Feb; 89(2):159-68. PubMed ID: 25808430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation.
    Tan X; Shi J; Fu Y; Gao C; Yang X; Li J; Wang W; Hou J; Li H; Zhou J
    Thromb Haemost; 2013 Jun; 109(6):1025-32. PubMed ID: 23571603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming limitations of microparticle measurement by flow cytometry.
    Lacroix R; Robert S; Poncelet P; Dignat-George F
    Semin Thromb Hemost; 2010 Nov; 36(8):807-18. PubMed ID: 21049381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An innovative flow cytometric approach for small-size platelet microparticles: influence of calcium.
    Montoro-García S; Shantsila E; Orenes-Piñero E; Lozano ML; Lip GY
    Thromb Haemost; 2012 Aug; 108(2):373-83. PubMed ID: 22740162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of procoagulant microparticles.
    Nomura S; Shimizu M
    J Intensive Care; 2015; 3(1):2. PubMed ID: 25705427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticle and Atherothrombotic Diseases.
    Nomura S
    J Atheroscler Thromb; 2016; 23(1):1-9. PubMed ID: 26412494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procoagulant microparticles in dogs with immune-mediated hemolytic anemia.
    Kidd L; Geddings J; Hisada Y; Sueda M; Concannon T; Nichols T; Merricks E; Mackman N
    J Vet Intern Med; 2015; 29(3):908-16. PubMed ID: 25871966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tissue factor in hemostasis and thrombosis.
    Mackman N
    Blood Cells Mol Dis; 2006; 36(2):104-7. PubMed ID: 16466951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procoagulant activity induced by transcatheter closure of atrial septal defects is associated with exposure of phosphatidylserine on microparticles, platelets and red blood cells.
    Ding W; Kou J; Meng H; Kou Y; He Z; Cao M; Wang L; Bi Y; Thatte HS; Shi J
    Thromb Res; 2015 Aug; 136(2):354-60. PubMed ID: 26099643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Yuana Y; Bertina RM; Osanto S
    Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function and role of microparticles in various clinical settings.
    Nomura S; Ozaki Y; Ikeda Y
    Thromb Res; 2008; 123(1):8-23. PubMed ID: 18667228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Santilli F; Marchisio M; Lanuti P; Boccatonda A; Miscia S; Davì G
    Thromb Haemost; 2016 Aug; 116(2):220-34. PubMed ID: 27173919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold.
    Chan KS; Sparrow RL
    Transfusion; 2014 Aug; 54(8):1935-44. PubMed ID: 24635475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment.
    Rousseau M; Belleannee C; Duchez AC; Cloutier N; Levesque T; Jacques F; Perron J; Nigrovic PA; Dieude M; Hebert MJ; Gelb MH; Boilard E
    PLoS One; 2015; 10(1):e0116812. PubMed ID: 25587983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients.
    Yang C; Ma R; Jiang T; Cao M; Zhao L; Bi Y; Kou J; Shi J; Zou X
    Tumour Biol; 2016 Jun; 37(6):7881-91. PubMed ID: 26700666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.